Company intelligence / Profile preview

BluumBio

San Francisco / Berkeley*, California, United Statesbluumbio.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

BluumBio develops bespoke bio-based remediation solutions using engineered enzymes and organisms to rapidly clean soil, air, and water of industrial pollutants. Their approach accelerates natural degradation processes for more effective environmental cleanup. The company has developed products targeting petroleum hydrocarbons, PFAS (“forever chemicals”), pesticides, plastics, and other man-made contaminants. No clinical results are reported as their work is in environmental applications.

Therapeutic areas: Other
Modalities: Microbial-based solutionsEngineered bacteria and plantsEnzyme discovery and optimization
Industry: Non-Drug Biotech

Partnerships

Not explicitly listed; collaboration with academic institutions implied by team backgrounds but no specific corporate partnerships named.

Beyond the preview

Go deeper on BluumBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BluumBio.

Explore the full profile